241 related articles for article (PubMed ID: 10088206)
21. Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: implications for outpatient monitoring with B-type natriuretic peptide.
McNairy M; Gardetto N; Clopton P; Garcia A; Krishnaswamy P; Kazanegra R; Ziegler M; Maisel AS
Am Heart J; 2002 Mar; 143(3):406-11. PubMed ID: 11868044
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of heart failure using urinary natriuretic peptides.
Ng LL; Geeranavar S; Jennings SC; Loke I; O'Brien RJ
Clin Sci (Lond); 2004 Feb; 106(2):129-33. PubMed ID: 13678415
[TBL] [Abstract][Full Text] [Related]
23. Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure.
van den Berg MP; Tjeerdsma G; Jan de Kam P; Boomsma F; Crijns HJ; van Veldhuisen DJ
Eur J Heart Fail; 2002 Jun; 4(3):255-62. PubMed ID: 12034149
[TBL] [Abstract][Full Text] [Related]
24. Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy.
Rousseau MF; Gurné O; Duprez D; Van Mieghem W; Robert A; Ahn S; Galanti L; Ketelslegers JM;
J Am Coll Cardiol; 2002 Nov; 40(9):1596-601. PubMed ID: 12427411
[TBL] [Abstract][Full Text] [Related]
25. Measurement and significance of circulating natriuretic peptides in cardiovascular disease.
Sagnella GA
Clin Sci (Lond); 1998 Nov; 95(5):519-29. PubMed ID: 9791037
[TBL] [Abstract][Full Text] [Related]
26. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.
Kjaer A; Hesse B
Clin Physiol; 2001 Nov; 21(6):661-72. PubMed ID: 11722473
[TBL] [Abstract][Full Text] [Related]
27. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis.
Clerico A; Caprioli R; Del Ry S; Giannessi D
J Endocrinol Invest; 2001 Jan; 24(1):24-30. PubMed ID: 11227728
[TBL] [Abstract][Full Text] [Related]
28. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
Yoshimura M; Yasue H; Tanaka H; Kikuta K; Sumida H; Kato H; Jougasaki M; Nakao K
Br Heart J; 1994 Dec; 72(6):528-33. PubMed ID: 7857734
[TBL] [Abstract][Full Text] [Related]
29. Neuroendocrine testing in community patients with heart disease: plasma N-terminal proatrial natriuretic peptide predicts morbidity and mortality stronger than catecholamines and heart rate variability.
Nielsen OW; Rasmussen V; Christensen NJ; Hansen JF
Scand J Clin Lab Invest; 2004; 64(7):619-28. PubMed ID: 15513318
[TBL] [Abstract][Full Text] [Related]
30. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators.
Daggubati S; Parks JR; Overton RM; Cintron G; Schocken DD; Vesely DL
Cardiovasc Res; 1997 Nov; 36(2):246-55. PubMed ID: 9463636
[TBL] [Abstract][Full Text] [Related]
31. Natriuretic peptide biomarkers as information indicators in elderly patients with possible heart failure followed over six years: a head-to-head comparison of four cardiac natriuretic peptides.
Alehagen U; Svensson E; Dahlström U
J Card Fail; 2007 Aug; 13(6):452-61. PubMed ID: 17675059
[TBL] [Abstract][Full Text] [Related]
32. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
[TBL] [Abstract][Full Text] [Related]
33. Changes in the levels of plasma atrial natriuretic peptide, hemodynamic measurements, and the levels of vasoactive hormones during the clinical course of congestive heart failure.
Hara H; Ogihara T; Nakamaru M; Rakugi H; Tateyama H
Clin Cardiol; 1988 Nov; 11(11):743-7. PubMed ID: 2976625
[TBL] [Abstract][Full Text] [Related]
34. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.
Clerico A; Iervasi G; Del Chicca MG; Emdin M; Maffei S; Nannipieri M; Sabatino L; Forini F; Manfredi C; Donato L
J Endocrinol Invest; 1998 Mar; 21(3):170-9. PubMed ID: 9591213
[TBL] [Abstract][Full Text] [Related]
35. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure.
Mair J; Hammerer-Lercher A; Puschendorf B
Clin Chem Lab Med; 2001 Jul; 39(7):571-88. PubMed ID: 11522102
[TBL] [Abstract][Full Text] [Related]
36. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure.
Grantham JA; Borgeson DD; Burnett JC
Am J Physiol; 1997 Apr; 272(4 Pt 2):R1077-83. PubMed ID: 9140004
[TBL] [Abstract][Full Text] [Related]
37. Comparative bioactivity of atrial and brain natriuretic peptides in an ovine model of heart failure.
Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Nicholls MG; Richards AM
Clin Sci (Lond); 1997 Feb; 92(2):159-65. PubMed ID: 9059317
[TBL] [Abstract][Full Text] [Related]
38. Plasma neuro-endocrine activity in very elderly subjects and patients with and without heart failure.
Dutka DP; Olivotto I; Ward S; Nihoyannopoulos P; al-Subaili M; Oakley CM; Impallomeni M; Cleland JG
Eur Heart J; 1995 Sep; 16(9):1223-30. PubMed ID: 8582385
[TBL] [Abstract][Full Text] [Related]
39. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M
J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
[TBL] [Abstract][Full Text] [Related]
40. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP.
Gegenhuber A; Struck J; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
Clin Chem; 2006 May; 52(5):827-31. PubMed ID: 16543387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
